Sudden cardiac death due to ?2-agonist therapy: is a genetic basis overlooked?

dc.authorwosidaksoy, yüksel/ABH-1304-2021
dc.contributor.authorYalta, K.
dc.contributor.authorSivri, N.
dc.contributor.authorGeyik, B.
dc.contributor.authorAksoy, Y.
dc.contributor.authorYetkin, E.
dc.date.accessioned2024-06-12T11:19:48Z
dc.date.available2024-06-12T11:19:48Z
dc.date.issued2012
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage99en_US
dc.identifier.issn1995-1892
dc.identifier.issue2en_US
dc.identifier.pmid22447478en_US
dc.identifier.startpage98en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25349
dc.identifier.volume23en_US
dc.identifier.wosWOS:000305152500013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherClinics Cardive Publ Pty Ltden_US
dc.relation.ispartofCardiovascular Journal Of Africaen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRepolarizationen_US
dc.subjectAsthmaen_US
dc.titleSudden cardiac death due to ?2-agonist therapy: is a genetic basis overlooked?en_US
dc.typeLetteren_US

Dosyalar